Logo | Name | Σ | ||
---|---|---|---|---|
Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: Biotechnology Pharmaceutical | 1561 | 1421 | 60 | |
CNRS Innovation Filiale du CNRS & de BPI France. 30 ans d'expertise au service de l'innovation et du transfert de technologies. CNRS Innovation, established in 1992, is a French public limited company, now a subsidiary of the CNRS at 90% and 10% Bpifrance Financement. Its mission is to transfer innovative technologies, mainly originating from the CNRS, to the industry. Its action extends from the receipt of projects to the granting of exploitation rights through consulting in Intellectual Property strategies, participation in the filing of patent applications, seeking of industrial partners, negotiating and drafting of exploitation agreements, and management of patent portfolios. CNRS … Sectors: Research | 503 | 160 | 348 | |
Omnes A leading private equity firm dedicated to the energy transition and innovation. Omnes is a leading European private equity firm dedicated to the energy transition. With over €6 billion in assets under management, Omnes provides companies with the equity capital they need in order to grow. Its four core businesses are Renewable Energy, Resilient Cities, Deeptech Venture Capital and Co-investment. Our 70 employees are based in four offices in Paris, Bruxelles, Munich and Zurich. Omnes is committed to sustainability and ESG. It is a signatory of the United Nations Principles for Responsible Investment (PRI) and has a Gender Equality index … Sectors: Startup accelerator & VC | 338 | 178 | 189 | |
Boehringer Ingelheim Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: Animal Health Pharmaceutical | 1878 | 1262 | 258 |